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Summary
Background.  —  Although  widely  accepted  worldwide,  indications  for  percutaneous  valve
replacement  are  limited  to  treatment  of  dysfunction  of  prosthetic  conduits  inserted  in  the  right
ventricular  outﬂow  tract  (RVOT).  There  has  been  little  evaluation  of  the  use  of  the  Melody®
valve  for  patched  non-circular  pulmonary  pathways.
Aim.  —  To  evaluate  the  outcomes  of  Melody  valve  insertion  in  patients  with  a  patched  non-
circular RVOT.
Methods.  —  We  analysed  procedural  and  outcomes  data  from  34  patients  who  underwent  Melody
valve implantation  for  a  non-circular  RVOT.  RVOT  preparation  was  done  in  all  patients,  using
different techniques  (conventional,  Russian  doll  and/or  PA  jailing).  Melody  valve  insertion  was
performed concomitantly  in  most  patients.
Results.  —  All  procedures  were  successful.  Sixteen  patients  had  complex  additional  proce-
dures, including  the  jailing  technique  (n  =  5),  the  Russian  doll  technique  (n  =  6)  and  multiple
Abbreviations: CI, conﬁdence interval; PA, pulmonary artery; PPVI, percutaneous pulmonary valve implantation; RV, right ventricle;
VOT, right ventricular outﬂow tract.
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Transcatheter  pulmonary  valvulation  in  RV  outﬂow  tracts  593
stent  implantations  (Russian  jailing;  n  =  5).  The  remaining  patients  were  treated  using  the
conventional  technique  with  systematic  prestenting.  Three  early  complications  occurred:  one
haemoptysis;  one  residual  RVOT  obstruction  needing  recatheterization  48  hours  after  percuta-
neous pulmonary  valve  implantation;  and  one  stent  embolization  during  advancement  of  the
Ensemble® delivery  system.  The  mean  follow-up  period  was  2.6  years  postprocedure.  There
was no  stent  fracture,  migration  or  embolization.  Two  patients  developed  a  signiﬁcant  para-
prosthetic leak  and  one  received  a  second  Melody  valve.
Conclusions.  —  Careful  patient  selection,  balloon  sizing  and  RVOT  preparation  with  prestenting
are required  to  create  a  safe  landing  zone  for  the  Melody  valve.  Short-term  follow-up  shows
excellent results  with  no  stent  fracture  or  migration  and  appears  promising.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  —  Bien  que  largement  acceptées  dans  le  monde,  les  indications  de  valvulation  per-
cutanée sont  limitées  au  traitement  des  dysfonctionnements  de  conduits  prothétiques  de  la
voie d’éjection  droite  (VD-AP).  L’utilisation  de  la  valve  Melody  (Medtronic  Inc.,  Minneapolis,
Minnesota,  États-Unis)  a  été  peu  évaluée  pour  les  voies  pulmonaires  patchées  non  circonféren-
tielles.
But. —  Nous  avons  évalué  le  devenir  de  l’implantation  de  Melody  chez  des  patients  avec  une
voie VD-AP  patchée  non  circonférentielle.
Méthodes.  —  Nous  avons  analysé  les  données  de  procédure  et  le  devenir  de  34  patients  ayant
rec¸u une  valve  Melody.  La  voie  VD-AP  a  été  préparée  chez  tous  les  patients  avant  la  valvu-
lation par  un  préstenting  en  utilisant  quatre  techniques  (la  technique  conventionnelle,  la
technique des  poupées  russes  et  la  technique  d’emprisonnement  d’une  AP  associée  ou  non
à la  précédente).  La  valvulation  a  été  simultanée  chez  la  grand  emajorité  des  patients.
Résultats.  —  Toutes  les  procédures  ont  été  réalisées  avec  succès.  Tous  ont  été  préstenté  avant
la valvulation.  Dix-huit  ont  été  traité  de  manière  conventionnelle.  Cinq  ont  eu  une  technique
d’emprisonnement,  6  celle  des  poupées  russes  et  5  une  technique  combinée.  Trois  complications
précoces  sont  survenues  :  une  hémoptysie  spontanément  résolutive;  un  obstacle  résiduel  qui  a
nécessité  un  nouveau  cathétérisme  48  heures  après  la  Melody;  et  une  embolisation  précoce  de
stent. Le  suivi  moyen  après  la  procédure  était  de  2,6  ans.  Aucun  patient  n’a  eu  de  fracture  de
stent, de  migration  ou  d’embolisation  de  stents.  Deux  patients  ont  eu  une  fuite  paraprothétique
dont un  a  nécessité  la  pose  d’une  deuxième  Melody.
Conclusions.  — Une  sélection  soigneuse  des  patients,  une  calibration  au  ballonet  et  une  pré-
paration de  la  voie  VD-AP  avec  préstenting  utilisant  une  technique  classique,  la  technique  des
poupées russes  ou  d’emprisonnement  sont  nécessaires  pour  créer  une  zone  d’accrochage  pour
insérer la  valve  Melody  aux  patients  ayant  des  voies  VD-AP  patchées.  À  court  terme,  les  résultats
sont encourageants  et  prometteurs  sans  fracture  de  stent  ni  embolisation.
© 2014  Elsevier  Masson  SAS.  Tous  droits  réservés.
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Percutaneous  pulmonary  valve  replacement  using  the
transcatheter  technique  is  now  accepted  and  practiced
worldwide  for  dysfunctional  right  ventricular  outﬂow  tracts
(RVOTs)  [1,2].  The  Melody® valve  (Melody  transcatheter  pul-
monary  valve;  Medtronic  Inc.,  Minneapolis,  MN,  USA)  is
available  in  a  single  diameter  of  18  mm,  dilatable  up  to
22  mm.  Currently,  indications  are  limited  to  dysfunctional
RVOT  circumferential  conduits  with  a  diameter  ≤  22  mm
[2].  Until  recently,  patched  or  native  non-circular  RVOTs
were  considered  a  relative  contraindication  to  transcatheter
valvulation,  but  off-label  uses  of  the  valve  in  patched  or
large  outﬂow  tracts  are  increasingly  reported  in  the  liter-
ature  [3—6].  The  majority  of  patients  requiring  valvulation
s
c
po  not  have  a  circular  conduit.  Indeed,  a  large  number  of
atients  have  a  patched  native  outﬂow  tract  after  tetral-
gy  of  Fallot  repair  with  the  transannular  patch  technique.
ome  patients  with  operated  tetralogy  of  Fallot  or  other
perated  congenital  heart  diseases  have  right  ventricle  (RV)
o  pulmonary  artery  (PA)  conduits  that  have  been  enlarged
ith  a  patch  during  reintervention  for  stenosis.  The  issues
ith  percutaneous  treatment  of  native  outﬂow  tract  or  non-
ircular  outﬂow  tract  are  the  size  of  the  outﬂow  tract,  the
bsence  of  a  landing  zone  and  the  non-circular  shape  of  the
utﬂow  tract.  We  sought  to  review  our  experience  with  non-
ircular  RVOTs,  describing  technical  issues  related  to  this
peciﬁc  type  of  anatomy  and  to  study  the  outcome  of  per-
utaneous  pulmonary  valve  implantation  (PPVI)  in  a  larger
opulation.
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ethods
ll  patients  who  had  received  a  Melody  valve  in  our  cen-
re  since  2009  were  reviewed  and  included  in  this  study.
atients  who  had  received  a  Melody  valve  in  a  non-circular
utﬂow  tract  (deﬁned  as  patients  with  no  conduit,  hetero-
rafts  or  homografts)  were  identiﬁed  in  the  cohort.  Data
ere  extracted  from  the  database  and  reviewed  for  this
aper.
All  patients  had  a  preimplantation  evaluation,  includ-
ng  clinical  examination,  echocardiography  and  cardiac
agnetic  resonance  imaging  (MRI)  or  cardiac  computed
omography  in  case  of  contraindication  to  magnetic  res-
nance  imaging.  All  procedures  were  performed  under
eneral  anaesthesia.  Informed  consent  approved  by  an  ethi-
al  committee  was  obtained  from  each  patient  and/or  their
arents.  Informed  consent  speciﬁed  that  patients  were  eli-
ible  for  Melody  valve  implantation  if  a  proper  landing  zone
as  present,  either  because  of  the  existence  of  a  circular
onduit/homograft/heterograft  or  because  of  a  calibrated
atched  RVOT.  In  the  context  of  native  tissue,  the  informed
onsent  clearly  speciﬁed  that  the  patient  needed  a stent
rior  to  Melody  valve  insertion  to  create  a  landing  zone.
Cardiac  catheterization  was  performed  via  percutaneous
uncture  of  the  femoral  or  jugular  vein.  The  femoral  artery
as  also  accessed  percutaneously  for  a  coronary  angiogram,
o  rule  out  any  potential  compression  on  the  coronary  arter-
es.
The  haemodynamics  and  anatomy  of  the  outﬂow  tract
nd  pulmonary  arteries  were  assessed  carefully.  Dimensions
f  the  RVOT  were  measured  in  at  least  two  planes  (lat-
ral  view  and  craniocaudal  view).  In  cases  with  stenosis,
ssessment  of  the  outﬂow  tract  was  done  using  the  con-
entional  technique,  using  a  high-pressure  balloon  (Atlas®
alloon;  Bard  Medical,  Covington,  GA,  USA).  In  cases  with
egurgitation  alone,  balloon  calibration  was  done  with  a  low-
ressure  compliant  balloon  (Tyshak® or  PTS®; NuMED  Inc.,
opkinton,  NY,  USA).  The  position  of  the  coronary  arter-
es  was  screened  using  coronary  and/or  aortic  angiograms
uring  RVOT  balloon  inﬂation.
Prestenting  was  done  using  available  stents  (ev3  MaxTM
D,  ev3  Endovascular  Inc.,  Plymouth,  MN,  USA;  CP  StentTM,
uMED,  Inc.,  Hopkinton,  NY,  USA).  Patients  were  considered
uitable  for  Melody  valve  placement  if  an  appropriate  land-
ng  zone  could  be  created  or  existed.  Patients  with  pure
ulmonary  regurgitation  and  RVOT/PA  >  26  mm  in  diameter
ere  considered  for  surgical  valvulation.  Different  tech-
iques  were  used  to  make  implantation  possible  in  case  of
arge  RVOT.  These  techniques  have  been  reported  in  detail
reviously.  Brieﬂy,  the  Russian  doll  technique  consisted  of
educing  the  RVOT  diameter  by  overlapping  multiple  stents
usually  covered).  The  jailing  technique  consisted  of  using  a
A  branch  to  construct  a  safe  landing  zone  in  the  RVOT.  A  ﬁrst
pen-cell  stent  was  positioned  in  the  proximal  left  or  right  PA
ver  a  22  mm  balloon.  A  second  stent  was  implanted  using  a
2  mm  balloon  inside  the  ﬁrst  one  with  an  overlap  of  around
0%  directed  to  the  RVOT.  The  Melody  valve  (Model  PB10)
as  then  inserted  as  low  as  possible  and  well  below  the
ain  PA  bifurcation  inside  the  stent  of  known  diameter,  using
 22  mm  Ensemble® transcatheter  valve  delivery  system
NU10;  NuMED  Inc.,  Hopkinton,  NY,  USA).  Postdilatation  of
he  Melody  valve  using  a  balloon  of  appropriate  diameter  (22
l
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r  24  mm)  was  done  to  reduce  the  amount  of  paraprosthetic
eak.  If  the  RVOT  was  very  large,  thick  stents  (typically  cov-
red  stents)  were  placed  inside  the  bare-metal  stent  prior  to
elody  valve  implantation.  The  last  technique  combined  the
ussian  doll  and  jailing  techniques  (‘Russian  jailing’).  For  a
arge  RVOT  and  a  large  PA,  the  method  of  choice  was  the
ussian  doll  technique.  For  a  large  RVOT  with  favourable  PA
imensions,  the  jailing  technique  was  preferred.  A  combi-
ation  of  the  two  was  preferred  in  patients  with  a  very  large
VOT  and  favourable  PA  dimensions.  Patients  with  adequate
ize  were  treated  according  to  the  conventional  technique.
Haemodynamic  and  angiographic  assessments  were
epeated  after  PPVI  in  all  patients.  All  patients  received  hep-
rin  and  antibioprophylaxis  during  and  after  the  procedure
ccording  to  the  institutional  protocol  and  were  discharged
n  lifelong  aspirin.
Patients  were  scheduled  at  the  outpatient  clinic  1,  3,  6,
2  and  24  months  after  PPVI,  with  a  detailed  clinical  exam-
nation,  transthoracic  echocardiography  and  chest  X-ray  at
,  12  and  24  months.  Cine  angiography  was  only  considered
n  patients  with  suspected  stent  fracture,  pulmonary  regur-
itation,  increased  RVOT  and  signs  of  embolism.
esults
hirty-four  patients  were  identiﬁed  as  having  a  non-circular
onduit  in  our  database,  representing  20%  of  the  total  pop-
lation.
emographics
ean  age  at  implantation  was  26  ±  10  years  (Table  1).
verall,  58.9%  of  the  patients  had  tetralogy  of  Fallot  or
ulmonary  atresia  with  ventricular  septal  defect  (n  =  20/34;
5%  conﬁdence  interval  [CI]  40.7—75.4%);  67.6%  patients
ad  native  patched  RVOTs  (n  =  23/34,  95%  CI  51.9—83.4%);
nd  32.3%  had  patched  RVOT  conduits  (n  =  11/34,  95%  CI
6.6—48.1%).  Typically,  the  posterior  wall  of  the  conduits
as  preserved  and  enlarged  anteriorly  with  a  patch.  No
atient  had  a  surgical  valve.  Four  patients  were  known  to
ave  only  one  functional  PA  (11.7%,  95%  CI  0.9—22.6%).
rocedural data
he  procedures  were  straightforward,  with  a mean  dura-
ion  of  91  ±  37  minutes  (Table  2).  Prestenting  was  done
n  all  patients:  30  patients  had  a  bare-metal  stent  inser-
ion  at  the  time  of  PPVI  and  four  had  a stent  previously
mplanted  (two-stage  procedure).  Sixteen  patients  (47.1%,
5%  CI  29.8—64.9%)  had  complex  additional  procedures
ecause  of  pure  pulmonary  regurgitation  and  because  the
VOT  was  >  24  mm.  Additional  procedures  included  the  jail-
ng  technique  (n  =  5),  the  Russian  doll  technique  (n  =  6)  and
ultiple  stent  implantations  (Russian  jailing,  n  =  5).  The  Rus-
ian  jailing  technique  became,  with  time,  our  preferred
echnique  in  patients  with  large  RVOTs.  The  remaining
atients  (n  =  18,  52.9%,  95%  CI  36.2—69.7%)  had  stenotic
esions  and  were  treated  using  the  conventional  technique
ith  systematic  prestenting.
Three  early  complications  occurred,  giving  an  inci-
ence  of  8.8%  (95%  CI  1.9—23.3%).  One  patient  had  a
Transcatheter  pulmonary  valvulation  in  RV  outﬂow  tracts  595
Table  1  Demographic  data  (n  =  34).
Congenital  heart  diseasea 20  (58.9;  40.7—75.4)
TOF-pulmonary
atresia  +  VSD
6 (17.65;  4.84—30.46)
TGA-VSD-PS  2  (5.88;  0—13.79)
Aortic  stenosis  2  (5.88;  0—13.79)
Other  4  (11.76;  0.9—22.6)
Type  of  RVOTa
Patched  conduit  11  (32.3;  16.6—48.1)
Native  patched  RVOT  23  (67.6;  51.9—83.4)
Men/women  (n/n) 16/18
Mean  number  (range)  of
surgeries
2 (1—4)
Additional  lesionsa
One  patent  PA  4  (11.7;  0.9—22.6)
Mean  interval  ±  SD
between  surgery  and
PPVI  (years)
18 ±  9
PA: pulmonary artery; PPVI: percutaneous pulmonary valve
implantation; PS: pulmonary stenosis; RVOT: right ventricular
outﬂow tract; SD: standard deviation; TOF: tetralogy of Fallot;
TGA: transposition of the great arteries; VSD: ventricular septal
defect.
Table  3  Follow-up  data.
Median  (range)  duration  of
follow-up  (months)
31 (21—41)
Valve  function  on  last
echocardiograma
No  signiﬁcant  regurgitation 32  (94.1;  80.3—99.2)
Signiﬁcant  regurgitation 2  cases  of
paravalvular
regurgitation  (5.9;
0—13.8)
Additional  procedures  (n)
Valve  in  valve  procedure
(Melody  in  Melody)
1
Death  0
Stent  fracture  0
Stent  embolization  0
Endocarditis  0
a
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ba Data are number (%; 95% conﬁdence interval).
haemoptysis  (presumably  due  to  PA  trauma  with  the  wire)
that  resolved  spontaneously.  One  jailing  technique  patient
needed  recatheterization  48  hours  after  the  initial  proce-
dure  because  of  residual  RVOT  obstruction.  The  jailed  right
PA  was  largely  patent  but  the  blood  ﬂow  was  directed  toward
Table  2  Procedural  data.
Length  of  procedure  (minutes)  91  ±  37
Postprocedure
RV  to  PA  gradient  (mmHg)  9  ±  6
Prestenting  34
Additional  procedure
Jailing  5
Russian  doll  6
Combined  (Russian  jailing)  5
Conventional  procedure  18
Complications
RVOT  obstruction  (jailing
group)
1 (opening  of  the
stent  strut  of  the
jailed  PA)
Haemoptysis  1  (resolved
spontaneously)
Embolization  of  stent  (Russian
doll  group)
1  (secured  with  two
stents  followed  by
Melody  valve)
Data are mean ± standard deviation or number. PA: pulmonary
artery; RV: right ventricle; RVOT: right ventricular outﬂow
tract.
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he  hypoplastic  left  PA.  The  stent  jailing  the  right  PA  was
rossed  and  the  stent  struts  were  dilated.  As  a  result,  sys-
olic  RV  and  PA  pressures  dropped  to  40  mmHg  immediately
fter  the  procedure.  One  Russian  doll  technique  patient
ad  a  secondary  dislodgement;  the  stent  moved  from  its
osition  during  advancement  of  the  Ensemble  delivery  sys-
em.  The  stent  was  secured  using  two  additional  overlapping
are-metal  stents  and  we  proceeded  with  the  Melody  valve
nsertion  successfully.
ostprocedural evolution
fter  a mean  follow-up  of  2.6  years,  no  stent  migration
ccurred  (Table  3).  No  embolization  was  found.  No  stent
racture  was  noticed  throughout  the  follow-up.  Valve  func-
ion  was  excellent  in  most  patients  (n  =  32/34,  94.1%,  95%
I  80.3—99.2%),  with  regurgitation  being  absent  in  28
atients  and  trivial  in  four  patients.  Two  patients  experi-
nced  signiﬁcant  pulmonary  regurgitation  on  transthoracic
chocardiography;  these  patients  were  implanted  using  the
ailing  technique.  The  Melody  valve  was  inserted  before
he  gap  between  the  RVOT  and  the  implanted  bare-metal
tent  ﬁlled  the  space.  We  thought  wrongly  that  the  Melody
alve  would  ﬁll  the  gap.  After  our  experience  with  these
atients  we  became  more  cautious  about  this  space  and  our
referred  method  of  treatment  became  the  combined  tech-
ique.  Regurgitations  were  initially  related  to  paravalvular
eak  but  became  valvular  in  one  patient  (Figs.  1  and  2),  who
equired  a  second  intervention.  Intracardiac  echocardiogra-
hy  showed  complete  disappearance  of  the  valve  leaﬂets
nd  absence  of  paraprosthetic  leak.  The  patient  received  a
econd  Melody  valve  with  an  excellent  mid-term  (15-month)
esult.iscussion
he  Melody  valve  was  initially  developed  with  the  aim  of  pro-
onging  the  lifespan  of  surgically  implanted  RV  to  PA  conduits
596  S.  Malekzadeh-Milani  et  al.
Figure 1. Still-frame angiographic images from patient with redo Melody valve following the jailing technique. A. Angiogram showing
severe regurgitation despite the Melody valve being in place. B. Angiogram after insertion of a new Melody valve, showing restoration of
pulmonary valve function.
Figure 2. Still-frame echocardiographic images from patient with redo Melody valve following the jailing technique. A. Colour Doppler
image showing unrestrictive forward ﬂow through the Melody valve. B. Colour Doppler image during diastole showing free regurgitation;
note the absence of paraprosthetic leak. C. Image showing Melody valve; no valve leaﬂet could be found (the disappearance of the leaﬂets
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txplains the free regurgitation). D—F. Echocardiographic images obta
egurgitation (E); visualization of coapting leaﬂets of the new Melo
1,2].  The  device  had  good  and  sustained  haemodynamic
esults.  With  time,  modiﬁcation  of  the  technique,  with  rou-
ine  prestenting  of  patients,  improved  the  overall  results
f  the  procedure  [7].  Although  the  Melody  valve  is  still
ndicated  only  in  the  treatment  of  dysfunctional  RV  to  PA
onduits,  some  have  reported  the  use  of  the  Melody  valve
or  native  patched  RVOTs  or  patched  conduits.  Initial  reports
f  the  results  of  percutaneous  valvulation  in  these  settings
t
w
t
r after redo Melody valve: unrestrictive forward ﬂow (D); tiny central
lve (F).
ere  good  [3—5,8]. One  of  the  main  limitations  of  the
elody  valve  is  its  size:  it  is  available  in  a  single  diameter  of
8  mm,  dilatable  up  to  22  mm.  We  and  others  have  extended
he  indication  to  non-circular  RVOTs.  In  this  paper,  we  sought
o  review  the  characteristics  of  the  population  of  patients
ho  had  a  Melody  valve  implanted  in  a non-circular  outﬂow
ract,  and  to  review  technical  aspects  and  medium-term
esults  of  percutaneous  valvulation.
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[Transcatheter  pulmonary  valvulation  in  RV  outﬂow  tracts  
In  this  particular  population,  the  ﬁrst  haemodynamic
assessment  is  crucial.  Indeed,  if  a  stenotic  lesion  is
observed,  the  procedure  is  very  similar  to  that  for  a  circular
conduit.  This  ﬁnding  was  the  case  in  53%  of  our  popula-
tion  of  patched  RVOTs.  In  other  cases,  a  speciﬁc  technique
was  needed  to  make  patients  amenable  to  PPVI.  The  dimen-
sion  of  the  outﬂow  tract  needs  to  be  assessed  adequately.
Typically,  we  use  a  low-pressure  balloon  (Tyshak  or  PTS  bal-
loon)  to  localize  the  potential  site  for  the  bare-metal  stent
implantation  and  to  size  the  RVOT.  This  sizing  is  done  with
simultaneous  measurement  of  aortic  pressure,  which  should
drop  during  balloon  inﬂation.  Dye  injection  should  be  done
during  inﬂation  to  assure  that  no  contrast  goes  into  the  PA.
Our  team  has  described  interventional  techniques  to  cre-
ate  a  safe  landing  zone  in  order  to  be  able  to  implant  the
Melody  valve  [4].  One  of  the  techniques  is  the  jailing  tech-
nique,  with  stenting  of  one  PA  branch  down  to  the  main  PA
branch;  the  second  technique  is  the  Russian  doll  technique,
with  successive  implantation  of  stents  with  decremental  bal-
loon  diameters  to  reduce  the  diameter  of  the  RVOT  to  a  size
that  allows  Melody  valve  implantation.  The  third  technique
is  a  combination  of  the  ﬁrst  two  techniques.
The  ﬁrst  technique  was  used  if  the  diameter  of  one
of  the  PA  branches  was  <  22  mm  and  the  diameter  of  the
RVOT  was  >  22  mm.  The  stenting  is  started  from  the  small-
est  PA  branch  all  the  way  to  the  RVOT  with  overlapping  of
the  uncovered  stents  jailing  the  contralateral  PA.  Uncov-
ered  bare-metal  stents  with  open-cell  design  are  very
effective  in  this  situation.  In  the  second  technique,  thick
stents  —  typically  covered  stents  —  are  preferable.  In  the
jailing  technique,  it  is  difﬁcult  to  predict  if  the  Melody  valve
will  ﬁll  the  gap  between  the  bare-metal  stent  and  the  RVOT.
Two  patients  experienced  paravalvular  leak;  one  led  to  com-
plete  disappearance  of  the  Melody  leaﬂets.  As  a  result,
with  experience,  a  combination  of  the  two  methods  is  now
preferred.  We  tried  to  ﬁll  the  gap  with  successive  implanta-
tions  of  covered  stents  before  implanting  the  Melody  valve,
especially  in  very  large  RVOTs.  No  additional  paravalvular
leak  was  noticed.  Besides  this  complication,  we  had  no
secondary  embolization  or  stent  fracture.  Valve  function
remains  excellent.  We  included  patients  with  RVOT  diam-
eters  up  to  26  mm.  In  theory,  patients  with  larger  diameters
could  also  beneﬁt  from  this  technique  at  the  price  of  multi-
ple  stent  implantations  to  ﬁll  the  gap  between  the  wall  and
the  primary  stent.
Most  of  the  patients  had  a  one-step  procedure.  Some
authors  advocate  that  a  two-step  procedure  is  preferable
to  allow  embedding  of  the  stent  to  the  PA  wall.  How-
ever,  recrossing  the  previous  stent  can  be  challenging  and
increases  the  risk  of  crushing  the  stent  during  advancement
of  the  Melody  valve  delivery  system.  As  a  result,  we  usu-
ally  performed  Melody  valve  implantation  during  the  same
procedure.
Study limitations
This  review  presents  the  results  of  a  small  population  of
patients  with  various  anatomies;  robust  conclusions  would
require  a  larger  population  of  patients  with  a  longer  follow-
up  period  and  comparison  of  the  results  with  a  population
of  patients  with  RV  to  PA  conduits.
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In  addition,  because  we  developed  these  techniques  and
ushed  the  limits  of  PPVI,  the  number  of  patients  with  large
nrestricted  patched  RVOT  is  increasing,  but  PPVI  with  spe-
ial  techniques  remains  possible  in  fewer  than  10%.  One
hould  remember  that  most  of  these  patients  are  not  suit-
ble  for  PPVI  with  current  devices.  New  dedicated  devices
ill  help  to  increase  the  indications.
A systematic  review  of  stent  fracture  was  not  performed
n  these  patients.  Our  policy  regarding  stent  fracture  is  to
creen  patients  with  echocardiography  and  chest  X-ray.  If
 ﬁnding  could  be  related  to  stent  fracture  then  a  cine
ngiogram  is  performed.  Using  this  protocol  we  might  miss  a
ortion  of  stent  fracture.  However,  only  clinically  irrelevant
nd  insigniﬁcant  stent  fractures  would  be  missed.  Finally,
ne  should  remember  that  the  rate  of  stent  fracture  since
he  introduction  of  systematic  prestenting  is  very  low  in
ost  centres.  In  the  particular  setting  of  patched  RVOT,
he  risk  of  stent  fracture  is  higher.  However,  the  number
f  stents  placed  before  Melody  valve  insertion  is  also  more
mportant,  providing  more  support  and  reducing  the  risk,  at
east  in  theory.
onclusions
ercutaneous  valvulation  of  patched  non-circular  outﬂow
ract  is  feasible.  Careful  assessment  of  anatomy  and  haemo-
ynamics  are  crucial  to  determine  if  a  patient  needs  a
omplex  approach  or  a  conventional  technique  for  PPVI.  In
hese  patients,  prestenting  is  mandatory  to  create  a  safe
anding  zone  and  limit  the  risk  of  stent  fracture.  When  the
ailing  technique  is  used,  care  should  be  taken  to  ﬁll  the
ap  between  the  RVOT  and  the  bare-metal  stent  before  the
elody  valve  is  implanted,  to  avoid  paravalvular  leak.  Once
he  Melody  valve  is  successfully  implanted,  the  complica-
ion  rate  is  low  and  excellent  haemodynamic  results  are
ustainable.
isclosure of interest
.  Boudjemline  is  a  proctor  for  Medtronic.  The  other  authors
eclare  that  they  have  no  conﬂicts  of  interest  concerning
his  article.
cknowledgments
his  study  was  partially  funded  by  the  Ministry  of  Health
STIC  2008).  The  authors  thank  the  staff  of  the  URC  of
eorges-Pompidou  Hospital  for  their  help  during  the  clinical
tudy.
eferences
1] Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percuta-
neous replacement of pulmonary valve in a right-ventricle to
pulmonary-artery prosthetic conduit with valve dysfunction.
Lancet 2000;356:1403—5.
2] McElhinney DB, Hellenbrand WE, Zahn EM, et al. Short- and
medium-term outcomes after transcatheter pulmonary valve
5[
[
[
[
[98  
placement in the expanded multicenter US melody valve trial.
Circulation 2010;122:507—16.
3] Boshoff DE, Cools BL, Heying R, et al. Off-label use of percuta-
neous pulmonary valved stents in the right ventricular outﬂow
tract: time to rewrite the label? Catheter Cardiovasc Interv
2013;81:987—95.
4] Boudjemline Y, Brugada G, Van-Aerschot I, et al. Outcomes and
safety of transcatheter pulmonary valve replacement in patients
with large patched right ventricular outﬂow tracts. Arch Cardio-
vasc Dis 2012;105:404—13.
5] Boudjemline Y, Sarquella-Brugada G, Kamache I, et al. Impact
of right ventricular outﬂow tract size and substrate on outcomes
[S.  Malekzadeh-Milani  et  al.
of percutaneous pulmonary valve implantation. Arch Cardiovasc
Dis 2013;106:19—26.
6] Khambadkone S, Nordmeyer J, Bonhoeffer P. Percutaneous
implantation of the pulmonary and aortic valves: indications and
limitations. J Cardiovasc Med (Hagerstown) 2007;8:57—61.
7] Demkow M, Biernacka EK, Spiewak M, et al. Percutaneous pul-
monary valve implantation preceded by routine prestenting with
a bare metal stent. Catheter Cardiovasc Interv 2011;77:381—9.8] Momenah TS, El Oakley R, Al Najashi K, Khoshhal S, Al
Qethamy H, Bonhoeffer P. Extended application of percuta-
neous pulmonary valve implantation. J Am Coll Cardiol 2009;53:
1859—63.
